Filing Details

Accession Number:
0001567619-22-019213
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-04 20:20:13
Reporting Period:
2022-11-02
Accepted Time:
2022-11-04 20:20:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623715 Imago Biosciences Inc. IMGO Pharmaceutical Preparations (2834) 454915810
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861069 E. Amy Tapper C/O Imago Biosciences, Inc.
329 Oyster Point Blvd, 3Rd Floor
South San Francisco CA 94080
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-02 750 $2.52 119,797 No 4 M Direct
Common Stock Disposition 2022-11-02 750 $17.90 119,047 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-02 750 $0.00 750 $2.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,732 2021-01-01 2027-03-28 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.